Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is a promising small-cap healthcare stock focused on dermatological treatments. Its lead product, ZORYVE, shows market potential, with hedge fund interest and analyst ratings supporting its growth prospects.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing